Huberman Lab cover image

Peptide & Hormone Therapies for Health, Performance & Longevity | Dr. Craig Koniver

Huberman Lab

00:00

Optimize Growth with Synergistic Peptides

Combining growth hormone-releasing peptides, such as semerelin and GHRP6, with BPC-157 enhances the efficiency of growth hormone binding due to BPC's ability to upregulate growth hormone receptors. This synergy allows for reduced dosages of growth hormone-releasing peptides while achieving similar results. BPC-157, particularly in oral forms, shows promise as an anti-inflammatory agent, especially for gastrointestinal issues like Crohn's disease, ulcerative colitis, and leaky gut, due to its stability and effectiveness in the gut environment.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app